Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruirui Yang

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Frontiers in Neurology|January 23, 2026
Protocol for a randomized controlled trial evaluating the artificial intelligence health education accurately linking system in patients with mild-to-moderate strokeZhixia Liu, Yun-Hua Li, Yuan Fang, et al.
National Science Review|October 3, 2022
Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animalsShihua Li, Ruirui Yang, Di Zhang, et al.
Nature Aging|November 26, 2024
Age-related decline in CD8<sup>+</sup> tissue resident memory T cells compromises antitumor immunitySiyu Pei, Xiuyu Deng, Ruirui Yang, et al.
Nature Communications|July 14, 2023
Sequence-based drug design as a concept in computational drug designLifan Chen, Zisheng Fan, Jie Chang, et al.
Nature Immunology|February 15, 2024
Targeting JMJD1C to selectively disrupt tumor T<sub>reg</sub> cell fitness enhances antitumor immunityXuehui Long, Sulin Zhang, Yuliang Wang, et al.
Cell Research|October 27, 2022
Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemiaCheng-Long Hu, Bing-Yi Chen, Zijuan Li, et al.
Science Translational Medicine|May 6, 2026
Targeting RBPMS selectively eliminates FOXO1-mediated stem cell signatures in mouse models of acute myeloid leukemiaPing Liu, Sulin Zhang, Bing-Yi Chen, et al.
Cell Host & Microbe|February 6, 2021
Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon responseJing-Wen Lin, Chao Tang, Han-Cheng Wei, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Frontiers in Neurology|January 23, 2026
Protocol for a randomized controlled trial evaluating the artificial intelligence health education accurately linking system in patients with mild-to-moderate strokeZhixia Liu, Yun-Hua Li, Yuan Fang, et al.
National Science Review|October 3, 2022
Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animalsShihua Li, Ruirui Yang, Di Zhang, et al.
Nature Aging|November 26, 2024
Age-related decline in CD8<sup>+</sup> tissue resident memory T cells compromises antitumor immunitySiyu Pei, Xiuyu Deng, Ruirui Yang, et al.
Nature Communications|July 14, 2023
Sequence-based drug design as a concept in computational drug designLifan Chen, Zisheng Fan, Jie Chang, et al.
Nature Immunology|February 15, 2024
Targeting JMJD1C to selectively disrupt tumor T<sub>reg</sub> cell fitness enhances antitumor immunityXuehui Long, Sulin Zhang, Yuliang Wang, et al.
Cell Research|October 27, 2022
Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemiaCheng-Long Hu, Bing-Yi Chen, Zijuan Li, et al.
Science Translational Medicine|May 6, 2026
Targeting RBPMS selectively eliminates FOXO1-mediated stem cell signatures in mouse models of acute myeloid leukemiaPing Liu, Sulin Zhang, Bing-Yi Chen, et al.
Cell Host & Microbe|February 6, 2021
Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon responseJing-Wen Lin, Chao Tang, Han-Cheng Wei, et al.
Pageof 13